Lungpacer Medical Announces Presentation of DONATE Data Reporting an Increase in Availability of Donor Lungs (opens original article in a new tab)

Lungpacer Medical reported that a medical device improved the availability of donor lungs by reducing lung collapse and increasing transplant eligibility during a study presented at the American Transplant Congress 2026.

• Lungpacer Medical presented DONATE data showing transvenous phrenic nerve stimulation increased donor lung availability
• The study found 51.1% of donors had transplantable lungs after neurostimulation versus 33.7% with standard care
• Neurostimulation improved oxygenation and reduced lung collapse in brain-dead donors